Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Polymorphisms of Estrogen Metabolism-Related Genes and Prostate Cancer Risk in Two Populations of African Ancestry.

Brureau L, Moningo D, Emeville E, Ferdinand S, Punga A, Lufuma S, Blanchet P, Romana M, Multigner L.

PLoS One. 2016 Apr 13;11(4):e0153609. doi: 10.1371/journal.pone.0153609. eCollection 2016.

2.

Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens.

Cussenot O, Azzouzi AR, Nicolaiew N, Fromont G, Mangin P, Cormier L, Fournier G, Valeri A, Larre S, Thibault F, Giordanella JP, Pouchard M, Zheng Y, Hamdy FC, Cox A, Cancel-Tassin G.

J Clin Oncol. 2007 Aug 20;25(24):3596-602.

PMID:
17704407
3.

Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.

Suzuki K, Nakazato H, Matsui H, Koike H, Okugi H, Kashiwagi B, Nishii M, Ohtake N, Nakata S, Ito K, Yamanaka H.

Cancer. 2003 Oct 1;98(7):1411-6.

4.

Region 2 of 8q24 is associated with the risk of aggressive prostate cancer in Caribbean men of African descent from Guadeloupe (French West Indies).

Cancel-Tassin G, Romana M, Gaffory C, Blanchet P, Cussenot O, Multigner L.

Asian J Androl. 2015 Jan-Feb;17(1):117-9. doi: 10.4103/1008-682X.135127.

5.

Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Tang L, Yao S, Till C, Goodman PJ, Tangen CM, Wu Y, Kristal AR, Platz EA, Neuhouser ML, Stanczyk FZ, Reichardt JK, Santella RM, Hsing A, Hoque A, Lippman SM, Thompson IM, Ambrosone CB.

Carcinogenesis. 2011 Oct;32(10):1500-6. doi: 10.1093/carcin/bgr139. Epub 2011 Jul 18.

6.

Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study.

Han DF, Zhou X, Hu MB, Xie W, Mao ZF, Chen DE, Liu F, Zheng F.

Chin Med J (Engl). 2005 Sep 20;118(18):1507-16.

PMID:
16232327
7.

Role of single nucleotide polymorphisms in estrogen-metabolizing enzymes and susceptibility to uterine leiomyoma in Han Chinese: a case-control study.

Shen Y, Xu Q, Ren M, Cai Y, Xu J.

J Obstet Gynaecol Res. 2014 Apr;40(4):1077-84. doi: 10.1111/jog.12275. Epub 2013 Dec 10.

PMID:
24320736
8.

Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2).

Lunn RM, Bell DA, Mohler JL, Taylor JA.

Carcinogenesis. 1999 Sep;20(9):1727-31.

PMID:
10469617
9.

Cyp17 promoter variant associated with prostate cancer aggressiveness in African Americans.

Kittles RA, Panguluri RK, Chen W, Massac A, Ahaghotu C, Jackson A, Ukoli F, Adams-Campbell L, Isaacs W, Dunston GM.

Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):943-7.

10.

Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.

Zhang L, Gu L, Qian B, Hao X, Zhang W, Wei Q, Chen K.

Breast Cancer Res Treat. 2009 Mar;114(2):327-38. doi: 10.1007/s10549-008-9998-0. Epub 2008 Jul 16.

PMID:
18629629
11.

Chromosome 8q24 variants are associated with prostate cancer risk in a high risk population of African ancestry.

Okobia MN, Zmuda JM, Ferrell RE, Patrick AL, Bunker CH.

Prostate. 2011 Jul;71(10):1054-63. doi: 10.1002/pros.21320. Epub 2011 Jan 12.

12.

CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility.

Tüzüner BM, Oztürk T, Kisakesen HI, Ilvan S, Zerrin C, Oztürk O, Isbir T.

In Vivo. 2010 Jan-Feb;24(1):71-4.

PMID:
20133979
13.

Association of the polymorphisms of genes involved in androgen metabolism and signaling pathways with familial prostate cancer risk in a Japanese population.

Okugi H, Nakazato H, Matsui H, Ohtake N, Nakata S, Suzuki K.

Cancer Detect Prev. 2006;30(3):262-8. Epub 2006 Jul 20.

PMID:
16859836
14.

Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women.

Tworoger SS, Chubak J, Aiello EJ, Ulrich CM, Atkinson C, Potter JD, Yasui Y, Stapleton PL, Lampe JW, Farin FM, Stanczyk FZ, McTiernan A.

Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):94-101.

15.

Female reproductive factors, gene polymorphisms in the estrogen metabolism pathway, and risk of lung cancer in Chinese women.

Lim WY, Chen Y, Chuah KL, Eng P, Leong SS, Lim E, Lim TK, Ng A, Poh WT, Tee A, Teh M, Salim A, Seow A.

Am J Epidemiol. 2012 Mar 15;175(6):492-503. doi: 10.1093/aje/kwr332. Epub 2012 Feb 13.

PMID:
22331461
16.

Identifying susceptibility genes for prostate cancer--a family-based association study of polymorphisms in CYP17, CYP19, CYP11A1, and LH-beta.

Douglas JA, Zuhlke KA, Beebe-Dimmer J, Levin AM, Gruber SB, Wood DP, Cooney KA.

Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):2035-9.

17.

Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways.

Latil AG, Azzouzi R, Cancel GS, Guillaume EC, Cochan-Priollet B, Berthon PL, Cussenot O.

Cancer. 2001 Sep 1;92(5):1130-7.

PMID:
11571725
18.

Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women.

Miyoshi Y, Noguchi S.

Biomed Pharmacother. 2003 Dec;57(10):471-81. Review.

PMID:
14637391
19.

Polymorphisms in steroid hormone pathway genes and mammographic density.

Haiman CA, Hankinson SE, De Vivo I, Guillemette C, Ishibe N, Hunter DJ, Byrne C.

Breast Cancer Res Treat. 2003 Jan;77(1):27-36.

PMID:
12602902
20.

Lack of association between the functional polymorphisms in the estrogen-metabolizing genes and risk for hepatocellular carcinoma.

Yuan X, Zhou G, Zhai Y, Xie W, Cui Y, Cao J, Zhi L, Zhang H, Yang H, Zhang X, Qiu W, Peng Y, Zhang X, Yu L, Xia X, He F.

Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3621-7. doi: 10.1158/1055-9965.EPI-08-0742.

Supplemental Content

Support Center